Search

Your search keyword '"Levitt Gill"' showing total 188 results
Start Over Author "Levitt Gill" Language english
188 results on '"Levitt Gill"'

2. From long-term follow-up Recommendations for clinical practice to plain language summaries for childhood, adolescent, and young adult cancer survivors

Author

van den Oever, Selina R., Fuchs, Tessa, Levitt, Gill A., Haupt, Riccardo, Mulder, Renée L., Amariutei, Ana, Bardi, Edit, Becker, Tom, Brown, Morven, Gsell, Hannah, Hartogh, Jaap den, Essiaf, Samira, Muraca, Monica, Potter, Emma, Schneider, Carina, Sugden, Elaine, Tomášiková, Zuzana, Vermeulen, Herma, Kremer, Leontien C.M., Skinner, Roderick, and van der Pal, Helena J.H.

Published
2024
Full Text
View/download PDF

3. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

Author

Verrill Mark, Levitt Gill, Plummer Christopher J, Cornelius Victoria R, Smith Lesley A, Canney Peter, and Jones Alison

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background We conducted a systematic review and meta-analysis to clarify the risk of early and late cardiotoxicity of anthracycline agents in patients treated for breast or ovarian cancer, lymphoma, myeloma or sarcoma. Methods Randomized controlled trials were sought using comprehensive searches of electronic databases in June 2008. Reference lists of retrieved articles were also scanned for additional articles. Outcomes investigated were early or late clinical and sub-clinical cardiotoxicity. Trial quality was assessed, and data were pooled through meta-analysis where appropriate. Results Fifty-five published RCTs were included; the majority were on women with advanced breast cancer. A significantly greater risk of clinical cardiotoxicity was found with anthracycline compared with non-anthracycline regimens (OR 5.43 95% confidence interval: 2.34, 12.62), anthracycline versus mitoxantrone (OR 2.88 95% confidence interval: 1.29, 6.44), and bolus versus continuous anthracycline infusions (OR 4.13 95% confidence interval: 1.75, 9.72). Risk of clinical cardiotoxicity was significantly lower with epirubicin versus doxorubicin (OR 0.39 95% confidence interval: 0.20, 0.78), liposomal versus non-liposomal doxorubicin (OR 0.18 95% confidence interval: 0.08, 0.38) and with a concomitant cardioprotective agent (OR 0.21 95% confidence interval: 0.13, 0.33). No statistical heterogeneity was found for these pooled analyses. A similar pattern of results were found for subclinical cardiotoxicity; with risk significantly greater with anthracycline containing regimens and bolus administration; and significantly lower risk with epirubicin, liposomal doxorubicin versus doxorubicin but not epirubicin, and with concomitant use of a cardioprotective agent. Low to moderate statistical heterogeneity was found for two of the five pooled analyses, perhaps due to the different criteria used for reduction in Left Ventricular Ejection Fraction. Meta-analyses of any cardiotoxicity (clinical and subclinical) showed moderate to high statistical heterogeneity for four of five pooled analyses; criteria for any cardiotoxic event differed between studies. Nonetheless the pattern of results was similar to those for clinical or subclinical cardiotoxicity described above. Conclusions Evidence is not sufficiently robust to support clear evidence-based recommendations on different anthracycline treatment regimens, or for routine use of cardiac protective agents or liposomal formulations. There is a need to improve cardiac monitoring in oncology trials.

Published
2010
Full Text
View/download PDF

4. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group

Author

Bardi, Edit, Mulder, Renée L., van Dalen, Elvira C., Bhatt, Neel S., Ruble, Kathy A., Burgis, Jennifer, Castellino, Sharon M., Constine, Louis S., den Hoed, Caroline M., Green, Daniel M., Koot, Bart G.P., Levitt, Gill, Szonyi, László, Wallace, W. Hamish, Skinner, Roderick, Hudson, Melissa M., Kremer, Leontien C.M., Effinger, Karen E., and Bresters, Dorine

Published
2021
Full Text
View/download PDF

5. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

van Dalen, Elvira C., Mulder, Renée L., Suh, Eugene, Ehrhardt, Matthew J., Aune, Gregory J., Bardi, Edit, Benson, Bradley J., Bergler-Klein, Jutta, Chen, Ming H., Frey, Eva, Hennewig, Ulrike, Lockwood, Liane, Martinsson, Ulla, Muraca, Monica, van der Pal, Helena, Plummer, Chris, Scheinemann, Katrin, Schindera, Christina, Tonorezos, Emily S., Wallace, W. Hamish, Constine, Louis S., Skinner, Roderick, Hudson, Melissa M., Kremer, Leontien C.M., Levitt, Gill, and Mulrooney, Daniel A.

Published
2021
Full Text
View/download PDF

6. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

Author

van Kalsbeek, Rebecca J., van der Pal, Helena J.H., Kremer, Leontien C.M., Bardi, Edit, Brown, Morven C., Effeney, Rachel, Winther, Jeanette F., Follin, Cecilia, den Hartogh, Jaap, Haupt, Riccardo, Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Levitt, Gill, Loonen, Jacqueline J., Mangelschots, Marlies, Muraca, Monica, Renard, Marleen, Sabic, Harun, Schneider, Carina U., Uyttebroeck, Anne, Skinner, Roderick, and Mulder, Renée L.

Published
2021
Full Text
View/download PDF

7. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

van der Kooi, Anne-Lotte Lolkje Femke, Mulder, Renee L., Hudson, Melissa M., Kremer, Leontien C.M., Skinner, Rod, Constine, Louis S., van Dorp, Wendy, van Dulmen-den Broeder, Eline, Falck-Winther, Jeanette, Wallace, W. Hamish, Waugh, Jason, Woodruff, Teresa K., Anderson, Richard A., Armenian, Saro H., Bloemenkamp, Kitty W.M., Critchley, Hilary O.D., Demoor-Goldschmidt, Charlotte, Ehrhardt, Matthew J., Green, Daniel M., Grobman, William A., Iwahata, Yuriko, Krishna, Iris, Laven, Joop S.E., Levitt, Gill, Meacham, Lillian R., Miller, Emily S., Mulders, Annemarie, Polanco, Angela, Ronckers, Cécile M., Samuel, Amber, Walwyn, Tom, Levine, Jennifer M., and van den Heuvel-Eibrink, Marry M.

Published
2021
Full Text
View/download PDF

8. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer

Author

Byrne, Julianne, Alessi, Daniela, Allodji, Rodrigue S., Bagnasco, Francesca, Bárdi, Edit, Bautz, Andrea, Bright, Chloe J., Brown, Morven, Diallo, Ibrahima, Feijen, Elizabeth A.M. (Lieke), Fidler, Miranda M., Frey, Eva, Garwicz, Stanislaw, Grabow, Desiree, Gudmundsdottir, Thorgerdur, Hagberg, Oskar, Harila-Saari, Arja, Hau, Eva M., Haupt, Riccardo, Hawkins, Mike M., Jakab, Zsuzsanna, Jankovic, Momcilo, Kaatsch, Peter, Kaiser, Melanie, Kremer, Leontien C.M., Kuehni, Claudia E., Kuonen, Rahel, Ladenstein, Ruth, Lähteenmäki, Päivi Maria, Levitt, Gill, Linge, Helena, LLanas, Damien, Michel, Gisela, Morsellino, Vera, Mulder, Renee L., Reulen, Raoul C., Ronckers, Cécile M., Sacerdote, Carlotta, Skinner, Roderick, Steliarova-Foucher, Eva, van der Pal, Helena J., de Vathaire, Florent, Vũ Bezin, Giao, Wesenberg, Finn, Wiebe, Thomas, Winter, David L., Winther, Jeanette Falck, Witthoff, Elise, Zadravec Zaletel, Lorna, and Hjorth, Lars

Published
2018
Full Text
View/download PDF

9. The ‘Survivorship Passport’ for childhood cancer survivors

Author

Menoni, Stefania, Bergeron, Christophe, den Hartogh, Jaap, Karner, Sabine, Fresneau, Brice, Jones, Kathy Pritchard, Vassal, Gilles, Bode, Gerlind, Frey, Eva, Hennewig, Ulrike, Iris, Maia, Jakab, Zsuzsanna, Kosmidis, Helen, Kriviene, Izolda, Marquez, Catalina, Modan-Moses, Dalit, Panasiuk, Anna, Vetsch, Janine, Haupt, Riccardo, Essiaf, Samira, Dellacasa, Chiara, Ronckers, Cecile M., Caruso, Silvia, Sugden, Elaine, Zadravec Zaletel, Lorna, Muraca, Monica, Morsellino, Vera, Kienesberger, Anita, Blondeel, Anne, Saraceno, Davide, Ortali, Maurizio, Kremer, Leontien C.M., Skinner, Roderick, Roganovic, Jelena, Bagnasco, Francesca, Levitt, Gill A., De Rosa, Marisa, Schrappe, Martin, Hjorth, Lars, and Ladenstein, Ruth

Published
2018
Full Text
View/download PDF

12. Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)

Author

Jankovic, Momcilo, Haupt, Riccardo, Spinetta, John J., Beck, Joern D., Byrne, Julianne, Calaminus, Gabriele, Lackner, Herwig, Biondi, Andrea, Oeffinger, Kevin, Hudson, Melissa, Skinner, Roderick, Reaman, Gregory, van der Pal, Helena, Kremer, Leontien, den Hartogh, Jaap, Michel, Gisela, Frey, Eva, Bardi, Edit, Hawkins, Michael, Rizvi, Katie, Terenziani, Monica, Valsecchi, Maria Grazia, Bode, Gerlind, Jenney, Meriel, de Vathaire, Florent, Garwicz, Stanislaw, Levitt, Gill A., Grabow, Desiree, Kuehni, Claudia E., Schrappe, Martin, Hjorth, Lars, and participants in PanCare

Published
2018
Full Text
View/download PDF

13. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment

Author

Schoot, Reineke A., Slater, Olga, Ronckers, Cécile M., Zwinderman, Aeilko H., Balm, Alfons J.M., Hartley, Benjamin, van den Brekel, Michiel W., Gupta, Sanjeev, Saeed, Peerooz, Gajdosova, Eva, Pieters, Bradley R., Gaze, Mark N., Mandeville, Henry C., Fajardo, Raquel Davila, Chang, Yen Ch’ing, Gains, Jennifer E., Strackee, Simon D., Dunaway, David, Abela, Christopher, Mason, Carol, Smeele, Ludi E., Chisholm, Julia C., Levitt, Gill A., Kremer, Leontien C.M., Grootenhuis, Martha A., Maurice-Stam, Heleen, Stiller, Charles A., Hammond, Peter, Caron, Huib N., and Merks, Johannes H.M.

Published
2015
Full Text
View/download PDF

14. Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

Author

Hjorth, Lars, Haupt, Riccardo, Skinner, Roderick, Grabow, Desiree, Byrne, Julianne, Karner, Sabine, Levitt, Gill, Michel, Gisela, van der Pal, Helena, Bárdi, Edit, Beck, Jörn D., de Vathaire, Florent, Essig, Stefan, Frey, Eva, Garwicz, Stanislaw, Hawkins, Mike, Jakab, Zsuzsanna, Jankovic, Momcilo, Kazanowska, Bernarda, Kepak, Tomas, Kremer, Leontien, Lackner, Herwig, Sugden, Elaine, Terenziani, Monica, Zaletel, Lorna Zadravec, and Kaatsch, Peter

Published
2015
Full Text
View/download PDF

15. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

Armenian, Saro H, Hudson, Melissa M, Mulder, Renee L, Chen, Ming Hui, Constine, Louis S, Dwyer, Mary, Nathan, Paul C, Tissing, Wim J E, Shankar, Sadhna, Sieswerda, Elske, Skinner, Rod, Steinberger, Julia, van Dalen, Elvira C, van der Pal, Helena, Wallace, W Hamish, Levitt, Gill, and Kremer, Leontien C M

Published
2015
Full Text
View/download PDF

17. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

Mulder, Renée L, Kremer, Leontien C M, Hudson, Melissa M, Bhatia, Smita, Landier, Wendy, Levitt, Gill, Constine, Louis S, Wallace, W Hamish, van Leeuwen, Flora E, Ronckers, Cécile M, Henderson, Tara O, Dwyer, Mary, Skinner, Roderick, and Oeffinger, Kevin C

Published
2013
Full Text
View/download PDF

24. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study.

Author

de Baat, Esmée C., Feijen, Elizabeth A.M., Reulen, Raoul C., Allodji, Rodrigue S., Bagnasco, Francesca, Bardi, Edit, Belle, Fabiën N., Byrne, Julianne, van Dalen, Elvira C., Debiche, Ghazi, Diallo, Ibrahima, Grabow, Desiree, Hjorth, Lars, Jankovic, Momcilo, Kuehni, Claudia E., Levitt, Gill, Llanas, Damien, Loonen, Jacqueline, Zaletel, Lorna Z., and Maule, Milena M.

Published
2023
Full Text
View/download PDF

36. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms’ tumour: Results of a randomised trial (UKW3) by the UK Children’s Cancer Study Group

Author

Mitchell, Christopher, Pritchard-Jones, Kathy, Shannon, Rosemary, Hutton, Carolyn, Stevens, Suzanne, Machin, David, Imeson, John, Kelsey, Anna, Vujanic, Gordan M., Gornall, Peter, Walker, Jenny, Taylor, Roger, Sartori, Pat, Hale, Juliet, Levitt, Gill, Messahel, Boo, Middleton, Helen, Grundy, Richard, and Pritchard, Jon

Published
2006
Full Text
View/download PDF

44. Impact of era of diagnosis on cause‐specific late mortality among 77 423 five‐year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium.

Author

Byrne, Julianne, Schmidtmann, Irene, Rashid, Humayra, Hagberg, Oskar, Bagnasco, Francesca, Bardi, Edit, De Vathaire, Florent, Essiaf, Samira, Winther, Jeanette Falck, Frey, Eva, Gudmundsdottir, Thorgerdur, Haupt, Riccardo, Hawkins, Michael M., Jakab, Zsuzsanna, Jankovic, Momcilo, Kaatsch, Peter, Kremer, Leontien C. M., Kuehni, Claudia E., Harila‐Saari, Arja, and Levitt, Gill

Subjects
CHILDHOOD cancer, MORTALITY, LONG-term health care, CANCER diagnosis, DEATH rate
Abstract

Late mortality of European 5‐year survivors of childhood or adolescent cancer has dropped over the last 60 years, but excess mortality persists. There is little information concerning secular trends in cause‐specific mortality among older European survivors. PanCareSurFup pooled data from 12 cancer registries and clinics in 11 European countries from 77 423 five‐year survivors of cancer diagnosed before age 21 between 1940 and 2008 followed for an average age of 21 years and a total of 1.27 million person‐years to determine their risk of death using cumulative mortality, standardized mortality ratios (SMR), absolute excess risks (AER), and multivariable proportional hazards regression analyses. At the end of follow‐up 9166 survivors (11.8%) had died compared to 927 expected (SMR 9.89, 95% confidence interval [95% CI] 9.69‐10.09), AER 6.47 per 1000 person‐years, (95% CI 6.32‐6.62). At 60 to 68 years of attained age all‐cause mortality was still higher than expected (SMR = 2.41, 95% CI 1.90‐3.02). Overall cumulative mortality at 25 years from diagnosis dropped from 18.4% (95% CI 16.5‐20.4) to 7.3% (95% CI 6.7‐8.0) over the observation period. Compared to the diagnosis period 1960 to 1969, the mortality hazard ratio declined for first neoplasms (P for trend <.0001) and for infections (P <.0001); declines in relative mortality from second neoplasms and cardiovascular causes were less pronounced (P =.1105 and P =.0829, respectively). PanCareSurFup is the largest study with the longest follow‐up of late mortality among European childhood and adolescent cancer 5‐year survivors, and documents significant mortality declines among European survivors into modern eras. However, continuing excess mortality highlights survivors' long‐term care needs. What's new? Children and adolescents who survive cancer have increased mortality rates compared with the general population. Here, the authors investigated trends in mortality among European cancer survivors 5 or more years after diagnosis. They pooled data on more than 77 000 patients from 12 cancer registries and clinics across Europe. Patients were diagnosed between 1940 and 2018, and all‐cause mortality fell steeply during this period. However, excess mortality remained high, even for subjects in their 60s, highlighting the need for long term care for childhood cancer survivors. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

49. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study.

Author

Feijen, Elizabeth Arnoldina Maria, van Dalen, Elvira C., van der Pal, Heleen J. H., Reulen, Raoul C., Winter, David L., Keuhni, Claudia E., Morsellino, Vera, Alessi, Daniela, Allodji, Rodrigue S., Byrne, Julliana, Bardi, Edit, Jakab, Zsuzsanna, Grabow, Desiree, Garwicz, Stanislaw, Haddy, Nadia, Jankovic, Momcilo, Kaatsch, Peter, Levitt, Gill A., Ronckers, Cecile M., and Schindera, Christina

Subjects
CANCER survivors, CHILDHOOD cancer, CENTRAL nervous system tumors, ISCHEMIA, MEDICAL ethics, RESEARCH, MYOCARDIAL ischemia, RESEARCH methodology, DISEASE incidence, MEDICAL cooperation, EVALUATION research, RISK assessment, COMPARATIVE studies, LONGITUDINAL method
Abstract

Objective: In this report, we determine the cumulative incidence of symptomatic cardiac ischaemia and its risk factors among European 5-year childhood cancer survivors (CCS) participating in the PanCareSurFup study.Methods: Eight data providers (France, Hungary, Italy (two cohorts), the Netherlands, Slovenia, Switzerland and the UK) participating in PanCareSurFup ascertained and validated symptomatic cardiac events among their 36 205 eligible CCS. Data on symptomatic cardiac ischaemia were graded according to the Criteria for Adverse Events V.3.0 (grade 3-5). We calculated cumulative incidences, both overall and for different subgroups based on treatment and malignancy, and used multivariable Cox regression to analyse risk factors.Results: Overall, 302 out of the 36 205 CCS developed symptomatic cardiac ischaemia during follow-up (median follow-up time after primary cancer diagnosis: 23.0 years). The cumulative incidence by age 60 was 5.4% (95% CI 4.6% to 6.2%). Men (7.1% (95% CI 5.8 to 8.4)) had higher rates than women (3.4% (95% CI 2.4 to 4.4)) (p<0.0001). Of importance is that a significant number of patients (41/302) were affected as teens or young adults (14-30 years). Treatment with radiotherapy/chemotherapy conferred twofold risk (95% CI 1.5 to 3.0) and cases in these patients appeared earlier than in CCS without treatment/surgery only (15% vs 3% prior to age 30 years, respectively (p=0.04)).Conclusions: In this very large European childhood cancer cohort, we found that by age 60 years, 1 in 18 CCS will develop a severe, life-threatening or fatal cardiac ischaemia, especially in lymphoma survivors and CCS treated with radiotherapy and chemotherapy increases the risk significantly. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

50. Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.

Author

Mulder, Renée L., Hudson, Melissa M., Bhatia, Smita, Landier, Wendy, Levitt, Gill, Constine, Louis S., Wallace, W. Hamish, van Leeuwen, Flora E., Ronckers, Cécile M., Henderson, Tara O., Moskowitz, Chaya S., Friedman, Danielle N., Ng, Andrea K., Jenkinson, Helen C., Demoor-Goldschmidt, Charlotte, Skinner, Roderick, Kremer, Leontien C.M., and Oeffinger, Kevin C.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results